Helicobacter pylori infection and carcinogenesis of the stomach.

作者: H. Kuniyasu , W. Yasui , H. Yokozaki , E. Tahara

DOI: 10.1007/S004230050248

关键词: EpigeneticsHelicobacter pyloriTelomerase reverse transcriptaseTelomereCancer researchIntestinal metaplasiaCancerMedicineCarcinogenesisTelomerase

摘要: Introduction: Human stomach carcinogenesis occurs after a multi-step process of genetic and epigenetic alterations in oncogenes, tumor-suppressor genes, cell-adhesion molecules, telomere telomerase activity as well instability at several microsatellite loci. Results discussion: These sequential found gastric cancer differ between the two histological types, indicating that different pathways exist for well-differentiated or intestinal-type poorly differentiated diffuse-type cancers, even though both types may arise from epithelial ”stem cells”, which express human reverse transcriptase (hTERT) protein activity. Infection with Helicobacter pylori, evidently causes release reactive oxygen species (ROMs) nitrogen (NO), be strong trigger cell” hyperplasia intestinal metaplasia, followed by reduction increased hTERT overexpression. They precede DNA replication error, hypermethylation, CD44 abnormal transcript, p53 mutations, all occur least 30% metaplasias early events pathogenesis type cancer. Here, we propose new concept preneoplasic lesion, ”metaplastic dysplasia”, based on our molecular observations.

参考文章(37)
Hiroshi Yokozaki, Hiroki Kuniyasu, Shuho Semba, Wataru Yasui, Eiichi Tahara, Molecular Bases of Human Stomach Carcinogenesis Springer Japan. pp. 55- 70 ,(1997) , 10.1007/978-4-431-65915-0_6
Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Paula M. Vertino, Jean-Pierre Issa, ALTERATIONS IN DNA METHYLATION : A FUNDAMENTAL ASPECT OF NEOPLASIA Advances in Cancer Research. ,vol. 72, pp. 141- 196 ,(1998) , 10.1016/S0065-230X(08)60702-2
Goro Kajiyama, Hidetoshi Tahara, Toshinori Ide, Ryo Nakashio, Eiichi Tahara, Mikiya Kitamoto, Jerry W. Shay, Toshio Nakanishi, Telomerase Activity in Human Liver Tissues: Comparison between Chronic Liver Disease and Hepatocellular Carcinomas Cancer Research. ,vol. 55, pp. 2734- 2736 ,(1995)
Hidetoshi Tahara, Toshinori Ide, Hiroki Kuniyasu, Eiichi Tahara, Wataru Yasui, Jerry W. Shay, Hiroshi Yokozaki, Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clinical Cancer Research. ,vol. 1, pp. 1245- 1251 ,(1995)
Felicity E. B. May, Bruce R. Westley, Review: Trefoil Proteins: Their Role in Normal and Malignant Cells The Journal of Pathology. ,vol. 183, pp. 4- 7 ,(1997) , 10.1002/(SICI)1096-9896(199709)183:1<4::AID-PATH1099>3.0.CO;2-5
Teruyoshi Ue, Hiroshi Yokozaki, Yasuhiko Kitadai, Soichiro Yamamoto, Wataru Yasui, Takenori Ishikawa, Eiichi Tahara, Co‐expression of osteopontin and CD44v9 in gastric cancer International Journal of Cancer. ,vol. 79, pp. 127- 132 ,(1998) , 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V
Adrian Merlo, James G. Herman, Li Mao, Daniel J. Lee, Edward Gabrielson, Peter C. Burger, Stephen B. Baylin, David Sidransky, 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine. ,vol. 1, pp. 686- 692 ,(1995) , 10.1038/NM0795-686
O. Lefebvre, M.-P. Chenard, R. Masson, J. Linares, A. Dierich, M. LeMeur, C. Wendling, C. Tomasetto, P. Chambon, M.-C. Rio, Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein Science. ,vol. 274, pp. 259- 262 ,(1996) , 10.1126/SCIENCE.274.5285.259
Toru Hiyama, Hiroshi Yokozaki, Yasuhiko Kitadai, Eiji Tahara, Hidetoshi Tahara, Toshinori Ide, Ken Haruma, Wataru Yasui, Goro Kajiyama, Eiichi Tahara, In situ mRNA Hybridization Technique for Analysis of Human Telomerase RNA in Gastric Precancerous and Cancerous Lesions Japanese Journal of Cancer Research. ,vol. 89, pp. 1187- 1194 ,(1998) , 10.1111/J.1349-7006.1998.TB00514.X
K NISHIMURA, H YOKOZAKI, K HARUMA, G KAJIYAMA, E TAHARA, Alterations of the apc gene in carcinoma cell-lines and precancerous lesions of the stomach. International Journal of Oncology. ,vol. 7, pp. 587- 592 ,(1995) , 10.3892/IJO.7.3.587